화학공학소재연구정보센터
홈 로그인 로그아웃 연락처 사이트맵
Macromolecular Research, Vol.20, No.3, 327-334, March, 2012
DOI10.1007/s13233-012-0063-9  Export Citation
pH-Sensitive Degradable Hydrophobe Modified 1.8 kDa Branched Polyethylenimine as “Artificial Viruses” for Safe and Efficient Intracellular Gene Transfection
Meng Zheng, Chunmei Yang1, Fenghua Meng, Rui Peng2, and Zhiyuan Zhong†
  • Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, Department of Polymer Science and Engineering, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, P. R. China
  • 1Lanzhou Military Command Center for Disease Control and Prevention, Lanzhou, 730020, P. R. China
  • 2Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, 215123, P. R. China
E-mail:
1.8 kDa branched polyethylenimine (PEI) was modified with pH-sensitive degradable acetal containing hydrophobe, 2,4,6-trimethoxybenzylidene-tris(hydroxymethyl)ethane (TMB-THME), to enhance its DNA condensation under extracellular conditions as well as to achieve active DNA release inside cells. PEI-(TMBTHME)n conjugates in the amount of 1.8 kDa were prepared with varying degrees of substitution (DS) from 3.0, 5.7 to 10.1.Notably, dynamic light scattering (DLS) measurements showed that all three 1.8 kDa PEI-(TMB-THME)n conjugates could effectively condense DNA into nano-sized particles (189-197 nm) at N/P ratios ranging from 20/1 to 80/1. The surface charges of PEI-(TMB-THME)n polyplexes depending on DS and N/P ratios varied from +22 to +28 mV, which were comparable to or slightly higher than the unmodified 1.8 kDa PEI counterparts (~+22 to +23 mV). Under a mildly acidic condition mimicking that of endosomes, interestingly, 1.8 kDa PEI-(TMB-THME)n polyplexes were quickly unpacked to release DNA because of the pH-induced acetal degradation that transforms hydrophobic modification into hydrophilic modification. MTT assays demonstrated that all PEI-(TMB-THME)n polyplexes displayed low cytotoxicity (>80%) to 293T, and HeLa cells at N/P ratios ranging from 20/1 to 60/1. The in vitro gene transfection studies showed that the transfection activity of 1.8 kDa PEI was significantly enhanced by modifications with TMBTHME, in which transfection efficiencies increased with increasing DS. For example, 1.8 kDa PEI-(TMBTHME) 10.1 polyplexes displayed 250-fold and 80-fold higher transfection efficiencies than those of the unmodified 1.8 kDa PEI counterparts in 293T and HeLa cells, respectively, which were approximately 4-fold and 2-fold higher than that of 25 kDa PEI control. The superior transfection activity of 1.8 kDa PEI-(TMB-THME)10.1 polyplexes was also confirmed by confocal laser scanning microscopy (CLSM), which showed efficient delivery of DNA into the nuclei of 293T cells following 4 h transfection. Modification of low molecular weight PEI with pH-sensitive degradable hydrophobe has appeared to be highly promising in the development of “artificial viruses” for safe and efficient gene transfer.
Keywords:polyethylenimine;hydrophobic modification;pH-sensitive;degradable;gene delivery.
  1. Jeong JH, Kim SW, Park TG, Prog. Polym. Sci., 32, 1239 (2007)
  2. Mintzer MA, Simanek EE, Chem. Rev., 109, 259 (2008)
  3. Pack DW, Hoffman AS, Pun S, Stayton PS, Nat.Rev. Drug Discov., 4, 581 (2005)
  4. Park TG, Jeong JH, Kim SW, Adv. Drug Deliv. Rev., 58, 467 (2006)
  5. Schaffert D, Wagner E, Gene Ther., 15, 1131 (2008)
  6. Bonetta L, Nat. Methods., 2, 875 (2005)
  7. Lungwitz U, Breunig M, Blunk T, Gopferich A, Eur. J.Pharm. Biopharm., 60, 247 (2005)
  8. Godbey WT, Wu KK, Mikos AG, J. Biomed. Mater.Res., 45, 268 (1999)
  9. Arote R, Kim TK, Kim YK, Hwang SK, Jiang HL, Song HH, Nah JW, Cho MH, Cho CS, Biomaterials., 28, 735 (2007)
  10. Arote RB, Hwang SK, Yoo MK, Jere D, Jiang HL, Kim YK, Choi YJ, Nah JW, Cho MH, Cho CS, J.Gene Med., 10, 1223 (2008)
  11. Jeong JH, Christensen LV, Yockman JW, Zhong ZY, Engbersen FJ, Kim WJ, Feijen J, Kim SW, Biomaterials., 28, 1912 (2007)
  12. Jere D, Jiang HL, Arote R, Kim YK, Choi YJ, Cho MH, Akaike T, Cho CS, Expert Opin. Drug Deliv., 6, 827 (2009)
  13. Kim YH, Park JH, Lee M, Kim YH, Park TG, Kim SW, J. Control. Release., 103, 209 (2005)
  14. Liu J, Jiang XL, Xu L, Wang XM, Hennink WE, Zhuo RX, Bioconjug. Chem., 21, 1827 (2010)
  15. Luten J, van Nostruin CF, De Smedt SC, Hennink WE, J. Control. Release., 126, 97 (2008)
  16. Park MR, Han KO, Han IK, Cho MH, Nah JW, Choi YJ, Cho CS, J. Control. Release., 105, 367 (2005)
  17. Peng Q, Zhong ZL, Zhuo RX, Bioconjug. Chem., 19, 499 (2008)
  18. Petersen H, Merdan T, Kunath F, Fischer D, Kissel T, Bioconjug. Chem., 13, 812 (2002)
  19. Russ V, Elfberg H, Thoma C, Kloeckner J, Ogris M, Wagner E, Gene Ther., 15, 18 (2008)
  20. Russ V, Gunther M, Halama A, Ogris M, Wagner E, J.Control. Release., 132, 131 (2008)
  21. Wang YX, Chen P, Shen JC, Biomaterials., 27, 5292 (2006)
  22. Incani V, Lavasanifar A, Uludag H, Soft Matter., 6, 2124 (2010)
  23. Liu ZH, Zhang ZY, Zhou CR, Jiao YP, Prog. Polym. Sci., 35, 1144 (2010)
  24. Han SO, Mahato RI, Kim SW, Bioconjug. Chem., 12, 337 (2001)
  25. Thomas M, Klibanov AM, Proc. Natl. Acad. Sci. U.S.A., 99, 14640 (2002)
  26. Neamnark A, Suwantong O, Bahadur KCR, Hsu CYM, Supaphol P, Uludag H, Mol. Pharm., 6, 1798 (2009)
  27. Peng Q, Chen FJ, Zhong ZL, Zhuo RX, Chem. Commun., 46, 5888 (2010)
  28. Zheng M, Zhong YN, Meng FH, Peng R, Zhong ZY, Mol. Pharm., 8, 2434 (2011)
  29. Bae YM, Choi H, Lee S, Kang SH, Kim YT, Nam K, Park JS, Lee M, Choi JS, Bioconjug. Chem., 18, 2029 (2007)
  30. Cho KC, Choi SH, Park TG, Macromol. Res., 14(3), 348 (2006)
  31. Liu ZZ, Zheng M, Meng FH, Zhong ZY, Biomaterials., 32, 9109 (2011)
  32. Wang YH, Zheng M, Meng FH, Zhang J, Peng R, Zhong ZY, Biomacromolecules, 12(4), 1032 (2011)
  33. Gillies ER, Frechet JMJ, Bioconjug. Chem., 16, 361 (2005)
  34. Gillies ER, Jonsson TB, Frechet JMJ, J. Am. Chem. Soc., 126(38), 11936 (2004)
  35. Chen W, Meng FH, Cheng R, Zhong ZY, J. Control.Release., 142, 40 (2010)
  36. Chen W, Meng FH, Li F, Ji SJ, Zhong ZY, Biomacromolecules, 10(7), 1727 (2009)
  37. Grigsby CL, Leong KW, J. R. Soc. Interface., 7, S67 (2010)
  38. Wang T, Upponi JR, Torchilin VP, Int. J. Pharm., DOI: 10.1016/j.ijpharm.2011.07.013. (2011)